.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Chubb
Deloitte
Farmers Insurance
Cerilliant
Dow
Chinese Patent Office
Federal Trade Commission
Mallinckrodt

Generated: December 16, 2017

DrugPatentWatch Database Preview

Suppliers and packages for tradename: NEVIRAPINE

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
AurobindoNEVIRAPINEnevirapineSUSPENSION;ORAL077702ANDAAurobindo Pharma Limited65862-057-11100 mL in 1 BOTTLE (65862-057-11)
AurobindoNEVIRAPINEnevirapineSUSPENSION;ORAL077702ANDAAurobindo Pharma Limited65862-057-24240 mL in 1 BOTTLE (65862-057-24)
Alvogen MaltaNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL204621ANDAAlvogen Inc.47781-317-3030 TABLET in 1 BOTTLE (47781-317-30)
Apotex IncNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL205258ANDAApotex Corp60505-4058-010 BLISTER PACK in 1 CARTON (60505-4058-0) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Apotex IncNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL205258ANDAApotex Corp60505-4058-5500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4058-5)
Apotex IncNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL205258ANDAApotex Corp60505-4058-330 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4058-3)
Aurobindo Pharma LtdNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL208616ANDAAurobindo Pharma Limited65862-932-05500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-932-05)
Aurobindo Pharma LtdNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL208616ANDAAurobindo Pharma Limited65862-932-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-932-90)
Aurobindo Pharma LtdNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL208616ANDAAurobindo Pharma Limited65862-932-991000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-932-99)
Aurobindo Pharma LtdNEVIRAPINEnevirapineTABLET, EXTENDED RELEASE;ORAL207698ANDAAurobindo Pharma Limited65862-933-991000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-933-99)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Healthtrust
Cantor Fitzgerald
Chinese Patent Office
Farmers Insurance
Fuji
Argus Health
UBS
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot